We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest Whitepapers
Best Practices for Air Sampling in Veterinary Environments
Whitepaper

Best Practices for Air Sampling in Veterinary Environments

The quality of indoor air dramatically affects the health of animals and humans during livestock production. Airborne transmission has been suspected of being responsible for epidemics of highly infectious diseases in livestock production, and due to the COVID-19 pandemic, there has been increasing concern about the role of wild animals in the epidemiology of most zoonoses.
Autologous CAR T-Cell Manufacturing
Whitepaper

Autologous CAR T-Cell Manufacturing

Cell-based chimeric antigen receptor (CAR) T-cell therapies have rapidly advanced from preclinical research. This success has driven an influx of companies to further develop CAR T-cell constructs to make them more effective, safe and persistent.
Challenging Host Cell Protein Assays for Improved Risk Mitigation
Whitepaper

Challenging Host Cell Protein Assays for Improved Risk Mitigation

Host Cell Proteins (HCPs) are a heterogeneous, complex group of proteins that derived from the host cell. Regulatory agencies examine each protein drug on a case-by-case basis to determine appropriate maximum acceptable levels of HCPs considering patient risk.
Validation Guidance for Residual Host Cell DNA Testing
Whitepaper

Validation Guidance for Residual Host Cell DNA Testing

Development of a manufacturing process for a biotherapeutic that ensures consistent quality, purity and safety is a critical step in successfully developing the drug, getting it approved by regulatory agencies, and bringing it to the market.
Advancing the Development of Therapeutics Against Infectious Diseases
Whitepaper

Advancing the Development of Therapeutics Against Infectious Diseases

Novel and emerging infectious diseases can be a serious threat to human health and the global economy, as exhibited by the current SARS-CoV-2 outbreak. To mitigate these threats, it is necessary to initiate comprehensive containment strategies such as
Reliable Results from Cell-Based Bioassays
Whitepaper

Reliable Results from Cell-Based Bioassays

While common laboratory plastics are generally regarded as inert by researchers, some commonly used products such as pipette tips and sample tubes have been reported to leach chemical compounds including oleamide, erucamide and DiHEMDA.
Pharma Efficiencies, Data Compliance and Weighing Excellence
Whitepaper

Pharma Efficiencies, Data Compliance and Weighing Excellence

With time a precious commodity and ever-increasing regulatory scrutiny, pharmaceutical laboratories are always on the lookout for simple solutions to make their routine tasks easier.
Getting a Gene Therapy Product to Market: Pitfalls and How to Prevent Them
Whitepaper

Getting a Gene Therapy Product to Market: Pitfalls and How to Prevent Them

Gene therapy is rapidly gaining importance as a critical treatment modality in the prevention or cure of a wide range of diseases. However, getting a product to market for commercial use does not come without its challenges.
Profiling Host Responses in COVID-19 Infections
Whitepaper

Profiling Host Responses in COVID-19 Infections

Download this whitepaper to discover how next-generation ELISA technology can accelerate biomarker discovery and provide in-depth analysis of COVID-19 host cytokine levels.
Investigating Synthetic Immune Recruitment by Proximity Inducing Molecules
Whitepaper

Investigating Synthetic Immune Recruitment by Proximity Inducing Molecules

Download this whitepaper to learn how Octet® Bio-Layer Interferometry (BLI) assays can accelerate the advancement of lead compounds to in vivo validation studies.
Advertisement